Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934305 · ClinicalTrials.gov registry record · NA

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

A NA study of HIV and Substance Use Disorders, sponsored by Boston University.

Recruiting
Registry status
NA
Development phase
256
Enrollment target
2
Study locations

NCT05934305: Recruiting NA study of HIV and Substance Use Disorders, sponsored by Boston University.

NCT05934305 is a NA study of HIV and Substance Use Disorders that is actively recruiting participants, run by Boston University. The registered enrollment target is 256 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05934305, a NA study of HIV and Substance Use Disorders, is actively recruiting participants, sponsored by Boston University.

RECRUITING
Registry status
NA
Development phase
256 participants
Enrollment target
2
Study locations

Study Summary

People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER intervention, a virtually delivered 5-session text-enhanced psychobehavioral intervention designed to facilitate viral suppression by addressing internalized stigma and shame as barriers to engagement in HIV care among individuals living with HIV and SUDs in two locations with different levels of HIV resources (i.e., the Boston, Massachusetts and Miami, Florida metro areas). MATTER aims to mitigate the negative behavioral consequences of internalized stigma and shame on viral suppression by a) developing behavioral self-care goal setting skills and related self-efficacy, b) increasing metacognitive awareness (i.e., non-judgmental awareness of emotions and cognitions), and c) teaching and reinforcing compassionate self-restructuring (i.e., self- compassion), in addition to providing access to phone-based resource navigation. Scalable interventions such as MATTER are essential to our efforts to end the HIV epidemic in high priority regions.

Primary Outcome

Compare the proportion of participants randomized to the intervention to the proportion of those randomized to the time-matched control condition who are virally suppressed at the 12 months follow up visit.

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL Matter Intervention

Study Locations (2)

Florida

  • Florida International University - Miami

Massachusetts

  • Fenway Health - Boston

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2025-03-12
Est. Completion 2028-07
Phase NA
Boston University

185 total trials

What NCT05934305 shows while recruiting

NCT05934305 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Control Condition is the first listed.

NCT05934305 reports a single indexed study location in Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05934305 about?

NCT05934305 is a clinical study titled "Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders". People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER interven...

What is the current status of trial NCT05934305?

This trial is currently recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2025-03-12. Estimated completion is 2028-07.

What conditions does trial NCT05934305 study?

This clinical trial studies the following conditions: HIV, Substance Use Disorders.

What interventions are being tested in trial NCT05934305?

The interventions under investigation include: Control Condition (BEHAVIORAL), Matter Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05934305?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05934305 being conducted?

This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05934305's enrollment target sits among peer trials

256 81st of 303 higher than 219 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02464696 · 256 participants · NA

    Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • NCT03793062 · 256 participants

    Genetic and Epigenetic Basis of Chronic Wounds

  • NCT04322318 · 256 participants · Phase 2

    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • NCT04468360 · 256 participants · Phase 2

    Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05934305, the US trial registry maintained by the National Library of Medicine. NCT05934305 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.